Abstract:
© 2018 Elsevier B.V. The authors regret that the following corrigenda must be made to our previously published manuscript: 1. Section 3.1 sentence 4 should read “Finally, evidence of cardiac involvement included one or a combination of the following: elevated creatine kinase (CK), creatine kinase-myocardial band (CK-MB), troponin I, troponin T, B-type natriuretic peptide (BNP), an abnormal electrocardiogram (ECG), chest X-ray (CXR), echocardiogram (echo), cardiac MRI or endo-myocardial biopsy (including those taken at post-mortem).”2. Section 3.1 sentence 5 should read “Additionally, there was one case of what was labelled cardiomyopathy [13], one case of polyserositis [21], and one case of pneumonitis [60] that the authors believed could be myocarditis related.”3. Table 1 references [26] and [35] under “Treatment response” the medications should be levocarnitine and carvedilol respectively.4. Table 1 reference [67] under “Diagnosis” the diagnosis should be Thrombogenic myocarditis.The authors would like to apologise for any inconvenience caused.
